Overview

Ibuprofen Suspension Bioequivalence Study

Status:
Completed
Trial end date:
2015-08-25
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine the rate and extent of absorption of Ibuprofen suspension formulations.
Phase:
Phase 1
Details
Lead Sponsor:
Reckitt Benckiser Healthcare (UK) Limited
Treatments:
Ibuprofen